FDA inspections don’t arrive with much ceremony. There’s no buildup—just a badge, a few introductions, and then a steady stream of questions about your documents,
On March 11, 2026, the U.S. Food and Drug Administration (FDA) announced the launch of the Adverse Event Monitoring System (AEMS), a centralized, AI-driven platform
FDA’s Valentine’s Day Reminder for OTC Drug Claims
The Ongoing Impact of the Government Shutdown on FDA and Regulated Industry — and What Companies Should Prioritize
A Transformative Shift for Regulated Imports
The FTC’s July 2025 Crackdown on “Made in USA” Claims Puts Industry on Notice
